Mark Mallon

Insider Reports History

Entity
Individual
Location
C/O Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston, MA
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Mallon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEOGENOMICS INC Chief Executive Officer, Director Common Stock 368K $6.77M $18.39 Mar 1, 2022 Direct
NEOGENOMICS INC Chief Executive Officer, Director Stock Option (Right to Buy) 348K Mar 1, 2022 Direct

Insider Reports Filed by Mark Mallon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NEO NEOGENOMICS INC Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Executive Officer, Director
NEO NEOGENOMICS INC Dec 30, 2021 1 $0 4 Dec 30, 2021 Chief Executive Officer, Director
NEO NEOGENOMICS INC Dec 6, 2021 1 $521K 4 Dec 6, 2021 Chief Executive Officer, Director